The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection

The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection Prospective, Randomized, Controlled, Double Blind, Multi-centre Study.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01019447

Enrollment

701

Registered

2009-11-25

Start date

2009-11-30

Completion date

2011-03-31

Last updated

2011-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infection

Keywords

Surgical site infection, Antimicrobial triclosan-coated polyglactin 910 suture, Length of hospital stay, SSI

Brief summary

To compare conventional polyglactin 910 sutures with triclosan-coated polyglactin 910 antimicrobial sutures for the reduction of surgical site infections and any associated health and economic benefits.

Interventions

OTHERVicryl Plus

Triclosan-coated polyglactin 910 antimicrobial sutures (Vicryl Plus)

OTHERVicryl

Polyglactin 910 antimicrobial sutures (Vicryl)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients of different age * Gender * Risk factors and procedures candidate for surgical intervention during the period of the study

Exclusion criteria

* Patients with an established pre-operative infection at the operative site

Design outcomes

Primary

Measure	Time frame
Signs of Surgical Site Infections (SSI) according to Centers for Disease Control (CDC) criteria	30 days (or 1 year in case of prosthesis)

Secondary

Measure	Time frame
Post-operative hospital stay in days	30 days

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026